nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A whole food, plant-based randomized controlled trial in metastatic breast cancer: feasibility, nutrient, and patient-reported outcomes
|
Campbell, Erin K. |
|
|
206 |
2 |
p. 273-283 |
artikel |
2 |
Body composition measures as a determinant of Alpelisib related toxicity
|
Shachar, Eliya |
|
|
206 |
2 |
p. 369-376 |
artikel |
3 |
Breast cancer (BC) and severe COVID-19 (C-19) outcomes: a matched analysis
|
Sullivan, Marija |
|
|
206 |
2 |
p. 307-316 |
artikel |
4 |
Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO
|
Pizzamiglio, S. |
|
|
206 |
2 |
p. 285-294 |
artikel |
5 |
Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study
|
Allsopp, Rebecca C. |
|
|
206 |
2 |
p. 377-385 |
artikel |
6 |
Correction: Five-year survival prognosis of young, middle-aged, and elderly adult female invasive breast cancer patients by clinical and lifestyle characteristics
|
Teng, Yu-Tung |
|
|
206 |
2 |
p. 437-439 |
artikel |
7 |
Correction: Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
|
Wimmer, Kerstin |
|
|
206 |
2 |
p. 441 |
artikel |
8 |
Disentangling the relationships of body mass index and circulating sex hormone concentrations in mammographic density using Mendelian randomization
|
Haas, Cameron B. |
|
|
206 |
2 |
p. 295-305 |
artikel |
9 |
Ethnic disparities in breast cancer patterns in Brazil: examining findings from population-based registries
|
da Silva, Jessé Lopes |
|
|
206 |
2 |
p. 359-367 |
artikel |
10 |
Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer
|
Hsu, Robert |
|
|
206 |
2 |
p. 245-259 |
artikel |
11 |
First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN
|
Martínez-Jañez, N. |
|
|
206 |
2 |
p. 317-328 |
artikel |
12 |
Impact of HER2 status on clinicopathological characteristics and pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
|
Shi, Yue |
|
|
206 |
2 |
p. 387-395 |
artikel |
13 |
Measuring cfDNA integrity as a biomarker for predicting neoadjuvant chemotherapy response in breast cancer patients: a pilot study
|
Giro, Camila |
|
|
206 |
2 |
p. 329-335 |
artikel |
14 |
Measuring serum oestrogen levels in breast cancer survivors using vaginal oestrogens: a systematic review
|
Pearson, Antonia |
|
|
206 |
2 |
p. 215-226 |
artikel |
15 |
Neoadjuvant chemotherapy for triple-negative and Her2 +ve breast cancer: striving for the standard of care
|
Roberts, Amanda |
|
|
206 |
2 |
p. 227-244 |
artikel |
16 |
Prognostic significance and value of further classification of lymphovascular invasion in invasive breast cancer: a retrospective observational study
|
Zhang, Yuyang |
|
|
206 |
2 |
p. 397-410 |
artikel |
17 |
Racialized economic segregation and inequities in treatment initiation and survival among patients with metastatic breast cancer
|
Pittell, Harlan |
|
|
206 |
2 |
p. 411-423 |
artikel |
18 |
Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane
|
Bertelsen, Bjørn-Erik |
|
|
206 |
2 |
p. 347-358 |
artikel |
19 |
Tolerability and effectiveness of palbociclib in older women with metastatic breast cancer
|
Baltussen, Joosje C. |
|
|
206 |
2 |
p. 337-346 |
artikel |
20 |
Unveiling the potential of breast MRI: a game changer for BI-RADS 4A microcalcifications
|
Li, Shiping |
|
|
206 |
2 |
p. 425-435 |
artikel |
21 |
Uptake of screening and risk-reducing recommendations among women with hereditary breast and ovarian cancer syndrome due to pathogenic BRCA1/2 variants evaluated at a large urban comprehensive cancer center
|
Assad, Hadeel |
|
|
206 |
2 |
p. 261-272 |
artikel |